Skip to content

Combined treatment after a heart attack shows improvement, but comparative benefit remains unclear

A randomized trial examined Shexiang Baoxin Pill and Baduanjin alongside conventional care. The abstract mainly reports changes within the combined-treatment group.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Patients receiving the combined approach improved on heart function, anxiety, depression and quality-of-life measures. However, heart function improved in every group, and the abstract does not provide clear numerical comparisons between groups. These results therefore leave uncertainty about how much benefit came from adding the pill, Baduanjin or their combination.

Keep in mind

The abstract reports mainly within-group changes, without between-group effect estimates or confidence intervals. Reporting no severe adverse events does not establish safety beyond this trial.

THE NUMBERS, WITH CONTEXT

What researchers found

50.09% to 56.10%; P < .001

Left ventricular ejection fraction

Baseline versus follow-up over 6 months in the combined-treatment group; this is a within-group change, not a comparison with conventional care.

Medicine (Baltimore), 2025 · Original source ↓

What was measured

Researchers assessed cardiac function using left ventricular ejection fraction and used separate rating scales for anxiety, depression and quality of life. These measured outcomes do not establish whether treatment reduced later heart attacks or deaths.

Why the comparison matters

Improvement after treatment does not by itself show that an added intervention caused the improvement. Although the authors describe the combined group as improving most, the abstract does not quantify its advantage over the other groups.

CHECK THE ORIGINAL

The original publication

Efficacy and safety of Shexiang Baoxin Pill combined with Baduanjin in the treatment of acute myocardial infarction: A prospective randomized study.

Fan J, Xia Z, Miao M et al.
Medicine (Baltimore) · 2025

PubMed ID
40859564
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.